Zyn is a pouch containing nicotine powder that is intended to rest in a user's mouth while the stimulant is absorbed into their bloodstream. The FDA's authorization of Zyn marks the first time ...
ZYN pouches contain no tobacco, only nicotine, offering a potentially less harmful option for tobacco users, with lower ...
Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See ...
In a groundbreaking move for the industry, the FDA has authorized the marketing of ZYN nicotine pouches — the first product ...
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products ...
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...
The authorization means pouches can be marketed to adults 21 or older but doesn’t mean the products are “FDA approved.” ...
The Food and Drug Administration on Thursday cleared the most popular nicotine pouch in the United States to stay on the ...
Zyn products will be allowed to stay on the market after federal health officials Thursday said the popular nicotine pouches ...
British American Tobacco offers a compelling 8.5% yield and strong long-term growth potential. Read why dividend investors ...